Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.3999
-0.0050 (-1.23%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Pasithea Therapeutics Employees
Pasithea Therapeutics had 5 employees as of December 31, 2025. The number of employees increased by 1 or 25.00% compared to the previous year. That makes Pasithea Therapeutics the 41,780th largest employer in the world and 6,481st in the United States.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$4,258,324
Market Cap
13.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | 1 | 25.00% | 5 | 0 |
| Dec 31, 2024 | 4 | -4 | -50.00% | 4 | 0 |
| Dec 31, 2023 | 8 | -7 | -46.67% | 8 | 0 |
| Dec 31, 2022 | 15 | 10 | 200.00% | 15 | 0 |
| Dec 31, 2021 | 5 | 2 | 66.67% | 3 | 2 |
| Jun 30, 2021 | 3 | - | - | 1 | 2 |
| Mar 31, 2021 | 3 | - | - | 1 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| Fractyl Health | 100 |
| Daré Bioscience | 24 |
| BioCardia | 21 |
| SeaStar Medical Holding | 18 |
| Radiopharm Theranostics | 14 |
| Kiora Pharmaceuticals | 13 |
| Tvardi Therapeutics | 12 |
KTTA News
- 3 days ago - Pasithea Therapeutics announces PAS-004 data at ESMO - TheFly
- 3 days ago - Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Presented at ESMO Congress 2026 - GlobeNewsWire
- 6 days ago - Pasithea Therapeutics Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 6 weeks ago - Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference - GlobeNewsWire
- 6 weeks ago - Pasithea Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Pasithea Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences - GlobeNewsWire
- 2 months ago - Pasithea Therapeutics Quarterly report: Q2 2026 - Filings